Candesartan News and Research

RSS
China Pharma first quarter revenue increases 20% to $18.1 million

China Pharma first quarter revenue increases 20% to $18.1 million

Generic drugs to treat hypertension, heart failure could help NHS save £200 million

Generic drugs to treat hypertension, heart failure could help NHS save £200 million

China Pharma second-quarter revenue increases 22% to $16.6 million

China Pharma second-quarter revenue increases 22% to $16.6 million

Researchers find how angiotensin influences immune system

Researchers find how angiotensin influences immune system

ARBs may be linked with increased risk of developing cancer: US scientists

ARBs may be linked with increased risk of developing cancer: US scientists

Drug trend for children increased 10.8% in 2009 across America

Drug trend for children increased 10.8% in 2009 across America

China Pharma first-quarter revenue up 16% to $15.1 million

China Pharma first-quarter revenue up 16% to $15.1 million

China Pharma Holdings reports 21% increase in 2009 revenue

China Pharma Holdings reports 21% increase in 2009 revenue

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy: Study

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy: Study

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings announces completion of clinical trials for Candesartan

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy

High blood pressure drugs may be useful in preventing and treating diabetic retinopathy

Candesartan cilexetil reduces proteinuria in kidney disease patients

Candesartan cilexetil reduces proteinuria in kidney disease patients

Candesartan shown to be safe new therapy for genetic heart disease

Candesartan shown to be safe new therapy for genetic heart disease

Novel approaches to hypertension control

Novel approaches to hypertension control

Early blood pressure treatment with candesartan may postpone hypertension

Early blood pressure treatment with candesartan may postpone hypertension

Early treatment with pharmacological therapy may reduce hypertension

Early treatment with pharmacological therapy may reduce hypertension

Hypertension reduced with early intervention

Hypertension reduced with early intervention

Therapy for slightly raised blood pressure delays hypertension

Therapy for slightly raised blood pressure delays hypertension

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure

Trial sparks debate over treatment of diabetic hypertensives

Trial sparks debate over treatment of diabetic hypertensives